Stockreport

Albireo Achieves Significant Milestones for Odevixibat Across Multiple Diseases

Albireo Pharma, Inc.  (ALBO) 
Last albireo pharma, inc. earnings: 3/2 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.albireopharma.com/investor-relations
PDF — Reiterates Top Line Data on Phase 3 in PFIC Expected Mid-2020 —— To Initiate Pivotal Trials in Biliary Atresia and Alagille Syndrome in 2020 — BOSTON, Jan. 29, 2020 [Read more]